Sun Pharmaceutical and Concert Pharmaceuticals announced on Monday that they have executed an agreement under which Sun Pharma will acquire all outstanding shares of Concert through a tender offer for an upfront payment of $8.00 per share of common stock in cash, or $576 million in equity value.

Innobic (Asia) Co Ltd, a subsidiary of national oil and gas conglomerate PTT Plc which it co-owns with Aztiq HK Ltd, recently acquired Alvogen Emerging Markets Holdings Ltd (AEMH), a major shareholder of Lotus Pharmaceutical Ltd and the sole owner of Adalvo Ltd.